Maternal Iron Deficiency And/or Iron Deficiency Anemia to Neonatal Hemoglobin Concentration and Iron Stores

Launched by ASSIUT UNIVERSITY · Mar 7, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how a mother’s iron levels during pregnancy can affect her newborn's health, specifically their hemoglobin concentration and iron stores at birth. Hemoglobin is a protein in red blood cells that carries oxygen, and having enough iron is crucial for both mothers and babies. The study aims to understand the relationship between maternal iron deficiency and iron deficiency anemia (a condition where you don't have enough iron in your body) and the baby's health at the time of birth.

To participate in this trial, mothers need to be between 21 and 40 years old and must be pregnant with a single baby that is born at a healthy weight after a normal delivery. Unfortunately, women with certain pregnancy complications or health conditions, as well as babies with specific health issues, will not be eligible. If you decide to take part in the study, you’ll be providing important information that could help improve the health of future mothers and babies. Keep in mind that this trial is not yet recruiting participants, so more information will be available once it starts.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All pregnant women and their infant pairs who have given consent to participate.
• • Mothers Age: 21-40 years' old.
• • Term infants (37-42 weeks of gestation) with birth weight ≥2500 g born to mothers who had an uncomplicated normal singleton vaginal delivery or caesarian section delivery was included.
• Exclusion Criteria:
• • Mothers with a history of antepartum hemorrhage, pre-mature labor pain, high-risk pregnancy (eg. history of trauma and severe infection during pregnancy), severe hyperemesis, pre-eclampsia severe anemia requiring blood transfusion, and any chronic medical illnesses as: gestational diabetes, hypertension, hypothyroidism, epilepsy, liver disease, renal disease cardiorespiratory disease, immunodeficiency syndrome, and hematological (other causes of anemia)
• • infants who suspected with congenital and/or chromosomal anomalies and pathological jaundice, also multiple pregnancy was excluded from the study.
• • Mothers withdrew from given a written consent will be excluded from the study.